1. Home
  2. NUVL vs SOLS Comparison

NUVL vs SOLS Comparison

Compare NUVL & SOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$99.62

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

SOLS

Solstice Advanced Materials Inc.

N/A

Current Price

$73.45

Market Cap

12.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NUVL
SOLS
Founded
2017
2025
Country
United States
United States
Employees
N/A
4400
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
12.5B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
SOLS
Price
$99.62
$73.45
Analyst Decision
Strong Buy
Buy
Analyst Count
15
4
Target Price
$135.33
$72.75
AVG Volume (30 Days)
454.6K
2.4M
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
0.41%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.46
Revenue Next Year
$1,064.25
$5.00
P/E Ratio
N/A
$54.31
Revenue Growth
N/A
N/A
52 Week Low
$55.54
$40.43
52 Week High
$113.02
$84.44

Technical Indicators

Market Signals
Indicator
NUVL
SOLS
Relative Strength Index (RSI) 46.11 51.13
Support Level $98.37 $70.72
Resistance Level $107.13 $83.07
Average True Range (ATR) 3.64 3.16
MACD -0.21 -1.07
Stochastic Oscillator 38.38 23.41

Price Performance

Historical Comparison
NUVL
SOLS

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About SOLS Solstice Advanced Materials Inc.

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

Share on Social Networks: